---
title: Improve gait through smartphone training
nct_id: NCT07380737
phase: NA
status: RECRUITING
sponsor: Tel-Aviv Sourasky Medical Center
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07380737"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07380737"
last_fetched: "2026-05-10T14:04:39.616Z"
source: "Parkinson's Pathways (curated)"
---
# Improve gait through smartphone training

**Goal (in five words):** Improve gait through smartphone training

**Official Title:** Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study

**Trial ID:** [NCT07380737](https://clinicaltrials.gov/study/NCT07380737)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Tel-Aviv Sourasky Medical Center
- **Target Enrollment:** 30 participants
- **Start Date:** 2025-12-29
- **Completion Date:** 2026-08-31
- **Conditions:** Parkinson's Disease
- **Interventions:** Walking Tall App
- **Intervention Types:** BEHAVIORAL

## Summary For Families

The aim is to see if a smartphone app can help people with Parkinson's practice gait and balance exercises at home to improve walking quality and confidence between clinic visits. The Walking Tall App guides tailored walking exercises, uses your phone to cue steps and timing, tracks walking patterns, and gives feedback so you can work on step length, rhythm, and stability alongside your usual rehab. They are enrolling adults 40 to 85 with idiopathic Parkinson's at Hoehn and Yahr stage II or III while ON medication, who can walk independently for at least five minutes, have had stable medications for a month, are enrolled in the Ezra LeMarpe rehab program, and can use a smartphone. People with major cognitive problems, other conditions that affect gait, serious cardiovascular contraindications, or inability to use a smartphone are excluded.

## Eligibility

- **Minimum age:** 40 Years
- **Maximum age:** 85 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Clinical diagnosis of idiopathic Parkinson's disease (MDS criteria);
* Hoehn \& Yahr stage II-III (ON-medication state);
* Able to walk independently for ≥5 minutes;
* Stable medication for ≥1 month;
* Currently enrolled in a rehab program at Ezra LeMarpe;
* Able to provide written informed consent;

Exclusion Criteria:

* Musculoskeletal, neurological, or visual/hearing impairments affecting gait;
* Cognitive impairments or severe behavioral symptoms;
* History of stroke, severe TBI, or brain tumor;
* Cardiovascular contraindications;
* Inability to use a smartphone;
* Participation in other concurrent intervention studies.
```

## Locations (1)

- Tel Aviv Sourasky Medical Center (Ichilov Hospital), Tel Aviv, Israel _(32.0809, 34.7806)_
  - Sourasky Medical Cente — (CONTACT) — +972-3-6974000 — ichilov-intru@tlvmc.gov.il

## Central Contacts

- Marina Brozgol, MS — (CONTACT) — +972-3-6947514 — marinab@tlvmc.gov.il
- Tatyana Gurevich, Prof — (CONTACT) — tanyag@tlvmc.gov.il

---

*Canonical: https://parkinsonspathways.com/trial/NCT07380737*  
*HTML version: https://parkinsonspathways.com/trial/NCT07380737*  
*Source data: https://clinicaltrials.gov/study/NCT07380737*